MedTrace Logo

A Trial of High Power-Short Duration Versus Standard Power-Long Duration Radiofrequency Ablation for Treatment of Atrial Fibrillation

NCT04148664 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-08-16

No results posted yet for this study

Summary

This study is a prospective, randomized controlled study to compare overall clinical outcomes between High Power Short Duration (HPSD) and standard radiofrequency (RF) ablation settings for Atrial Fibrillation (AF) ablation in the treatment of subjects with paroxysmal or persistent Atrial Fibrillation.

Conditions

Interventions

PROCEDURE

Catheter ablation with Standard RF ablation settings

Standard RF ablation settings (n=30): Maximum 35W for 20-40 seconds, per operator standard.

PROCEDURE

Catheter ablation with High Power Short Duration RF ablation settings

High power short duration RF (n=30): Maximum 50 Watts for 5-15 seconds, per operator standard.

Sponsors & Collaborators

Principal Investigators

  • Edward P Gerstenfeld, MD · Chief of Cardiac Electrophysiology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-03
Primary Completion
2020-12-01
Completion
2022-12-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04148664 on ClinicalTrials.gov